Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials

被引:73
|
作者
Qiu, Shanhu [1 ,2 ]
Cai, Xue [1 ]
Chen, Xiang [1 ]
Yang, Bingquan [1 ]
Sun, Zilin [1 ]
机构
[1] Southeast Univ, Sch Med, Inst Diabet, Zhongda Hosp,Dept Endocrinol, Nanjing, Jiangsu, Peoples R China
[2] Univ Ulm, Sect Sports Med & Rehabil, Dept Med 2, D-89075 Ulm, Germany
来源
BMC MEDICINE | 2014年 / 12卷
关键词
Step counter; Type; 2; diabetes; Physical activity; Glycemic control; Meta-analysis; Randomized controlled trial; PHYSICAL-ACTIVITY INTERVENTION; OLDER-ADULTS; CARDIORESPIRATORY FITNESS; SEDENTARY BEHAVIOR; TELEPHONE SUPPORT; HEALTH OUTCOMES; PEDOMETER; EXERCISE; PROGRAM; RISK;
D O I
10.1186/1741-7015-12-36
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: While step counter use has become popular among type 2 diabetes (T2D) patients, its effectiveness in increasing physical activity (PA) and improving glycemic control has been poorly defined. The aim of this meta-analysis of randomized controlled trials (RCTs) was to evaluate the association of step counter use with PA and glycemic control in T2D patients. Methods: Articles were identified by searches of PubMed, Web of Science and Cochrane Library from January 1994 to June 2013. RCTs in the English language were included, if they had assessed the effectiveness of step counters as motivating and monitoring tools in T2D patients, with reported changes in steps per day (steps/d) or glycosylated hemoglobin A1c (HbA1c), or both. Data were independently collected by 2 authors and overall estimates were made by a random-effects model. Results: Of the 551 articles retrieved, 11 RCTs were included. Step counter use significantly increased PA by 1,822 steps/d (7 studies, 861 participants; 95% confidence interval (Cl): 751 to 2,894 steps/d) in patients with T2D. Step counter use with a PA goal showed a bigger increase in PA (weighted mean difference (WMD) 3,200 steps/d, 95% Cl: 2,053 to 4,347 steps/d) than without (WMD 598 steps/d, 95% Cl: -65 to 1,260 steps/d). Further subgroup analysis suggested step counter use with a self-set PA goal (WMD 2,816 steps/d, 95% Cl: 1,288 to 4,344 steps/d) made no difference in increasing PA from a 10,000 steps/d goal (WMD 3,820 steps/d, 95% Cl: 2,702 to 4,938 steps/d). However, no significant HbA1c change was observed by step counter use (10 studies, 1,423 participants; WMD 0.02%, 95% Cl: -0.08% to 0.13%), either with (WMD 0.04%, 95% Cl: -0.21% to 0.30%) or without a PA goal (WMD 0.01%, 95% Cl: -0.10% to 0.13%). Conclusions: Step counter use is associated with a significant increase in PA in patients with T2D. However, evidence regarding its effect in improving glycemic control remains insufficient.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials
    Shanhu Qiu
    Xue Cai
    Xiang Chen
    Bingquan Yang
    Zilin Sun
    [J]. BMC Medicine, 12
  • [2] Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults
    Zhang, Chengcheng
    Jiang, Jinchi
    Wang, Chen
    Li, Sijia
    Yu, Leilei
    Tian, Fengwei
    Zhao, Jianxin
    Zhang, Hao
    Chen, Wei
    Zhai, Qixiao
    [J]. CLINICAL NUTRITION, 2022, 41 (02) : 365 - 373
  • [3] Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials
    Balbi, Maria E.
    Tonin, Fernanda S.
    Mendes, Antonio M.
    Borba, Helena H.
    Wiens, Astrid
    Fernandez-Llimos, Fernando
    Pontarolo, Roberto
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [4] Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials
    Maria E. Balbi
    Fernanda S. Tonin
    Antonio M. Mendes
    Helena H. Borba
    Astrid Wiens
    Fernando Fernandez-Llimos
    Roberto Pontarolo
    [J]. Diabetology & Metabolic Syndrome, 10
  • [5] Efficacy and safety of canagliflozin in patients with type 2 diabetes A meta-analysis of randomized controlled trials
    Xiong, Wei
    Xiao, Ming Yue
    Zhang, Mei
    Chang, Fei
    [J]. MEDICINE, 2016, 95 (48) : e5473
  • [6] Safety and Efficacy of Efpeglenatide in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
    Escobar, Johao
    Monday, Obinna
    Vemoori, Yashwanth
    Yadav, Indresh
    Maslamani, Abdalkareem Nael Jameel
    Al Kutabi, Salem
    Saeed, Leena
    Khan, Areeba
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [7] Efficacy and safety of empagliflozin for type 2 diabetes mellitus Meta-analysis of randomized controlled trials
    Zhang, Yun-Jing
    Han, Shi-Liang
    Sun, Xi-Feng
    Wang, Shu-Xiang
    Wang, Hong-Yun
    Liu, Xiao
    Chen, Li
    Xia, Ling
    [J]. MEDICINE, 2018, 97 (43):
  • [8] Efficacy of lifestyle education to prevent type 2 diabetes - A meta-analysis of randomized controlled trials
    Yamaoka, K
    Tango, T
    [J]. DIABETES CARE, 2005, 28 (11) : 2780 - 2786
  • [9] Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Mao, Song
    Zhang, Aihua
    Huang, Songming
    [J]. ENDOCRINE, 2014, 47 (03) : 758 - 763
  • [10] Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Song Mao
    Aihua Zhang
    Songming Huang
    [J]. Endocrine, 2014, 47 : 758 - 763